The Ministry of Health has announced the successful procurement of 33,600 doses of the Mpox (monkeypox) vaccine as part of measures to strengthen the country’s preparedness and response to the viral disease.
The vaccines, acquired through international health partnerships and bilateral engagements, are expected to support ongoing efforts to protect vulnerable groups and prevent the further spread of Mpox in Ghana.
According to the Sector Minister, Kwabena Mintah Akandoh, the vaccine doses will be prioritised for health workers, high-risk communities, and individuals who may have been exposed to confirmed cases.
In an X post, Akandoh said “The Ministry of Health has successfully secured 33,600 vaccines to strengthen Ghana’s fight against MPOX. This marks another milestone in safeguarding the health and wellbeing of our citizens.”
The move comes amid concerns of rising global infections and renewed calls for African countries to secure equitable access to life-saving vaccines.
Mpox, a viral disease that causes skin lesions, fever, and fatigue, was declared a global health emergency in 2022.
Though cases in Ghana have remained relatively low compared to other regions, health experts warn that vaccination is key to preventing community transmission and protecting vulnerable groups.
The Ministry has urged the public to remain vigilant by reporting suspected cases early, adhering to preventive guidelines, and supporting vaccination drives.
Distribution of the vaccines is expected to begin in phases, starting with major hospitals and treatment centres.
The Ministry is also engaging regional health directorates to ensure a smooth rollout nationwide.
With this step, Ghana joins a growing number of countries in Africa taking proactive measures to curb the spread of Mpox through vaccination.
The death toll remains in Ghana at one, with no new fatalities and no patients currently hospitalised, the Ghana Health Service (GHS) has reported.